1. Home
  2. SGI vs BBIO Comparison

SGI vs BBIO Comparison

Compare SGI & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Somnigroup International Inc.

SGI

Somnigroup International Inc.

HOLD

Current Price

$63.94

Market Cap

13.3B

ML Signal

HOLD

Logo BridgeBio Pharma Inc.

BBIO

BridgeBio Pharma Inc.

HOLD

Current Price

$65.59

Market Cap

15.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGI
BBIO
Founded
1846
2015
Country
United States
United States
Employees
19000
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.3B
15.9B
IPO Year
2003
2019

Fundamental Metrics

Financial Performance
Metric
SGI
BBIO
Price
$63.94
$65.59
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
25
Target Price
★ $97.88
$86.33
AVG Volume (30 Days)
★ 3.2M
2.3M
Earning Date
05-07-2026
05-12-2026
Dividend Yield
★ 0.90%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 1.01
N/A
Revenue
★ $2,754,400,000.00
$502,076,000.00
Revenue This Year
$7.30
$89.45
Revenue Next Year
$4.99
$73.78
P/E Ratio
$61.69
★ N/A
Revenue Growth
N/A
★ 126.26
52 Week Low
$60.39
$50.68
52 Week High
$98.56
$93.42

Technical Indicators

Market Signals
Indicator
SGI
BBIO
Relative Strength Index (RSI) 45.54 28.95
Support Level $63.52 $63.47
Resistance Level $70.74 $70.49
Average True Range (ATR) 2.07 2.84
MACD -0.26 -0.40
Stochastic Oscillator 29.72 7.18

Price Performance

Historical Comparison
SGI
BBIO

About SGI Somnigroup International Inc.

Somnigroup International Inc is a bedding company, dedicated to improving people's lives through good sleep. With superior capabilities in design, manufacturing, distribution and retail, It delivers breakthrough sleep solutions and serves the evolving needs of consumers in more than 100 countries world-wide through its fully-owned businesses Mattress Firm, Tempur Sealy North America and Tempur Sealy International. The company's portfolio includes the brand such as Tempur-Pedic, Sealy and Stearns & Foster, and its Multinational omnichannel platform enables the company to meet consumers wherever shop, offering a personal connection and innovation to provide a retail experience and tailored solutions.

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Share on Social Networks: